Topic Highlight
Copyright ©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 14, 2012; 18(46): 6747-6755
Published online Dec 14, 2012. doi: 10.3748/wjg.v18.i46.6747
Laparoscopic rectal cancer surgery: Where do we stand?
Mukta K Krane, Alessandro Fichera
Mukta K Krane, Alessandro Fichera, Department of Surgery, University of Chicago Pritzker School of Medicine, 5841 South Maryland Ave, MC 5095, Chicago, IL 60637, United States
Author contributions: Krane MK and Fichera A equally contributed to this paper.
Correspondence to: Mukta K Krane, MD, Assistant Professor, Department of Surgery, University of Chicago Pritzker School of Medicine, 5841 South Maryland Ave, MC 5095, Chicago, IL 60637, United States. mkrane@surgery.bsd.uchicago.edu
Telephone: +1-773-8343986 Fax: +1-773-8341995
Received: April 18, 2012
Revised: October 10, 2012
Accepted: October 16, 2012
Published online: December 14, 2012

Abstract

Large comparative studies and multiple prospective randomized control trials (RCTs) have reported equivalence in short and long-term outcomes between the open and laparoscopic approaches for the surgical treatment of colon cancer which has heralded widespread acceptance for laparoscopic resection of colon cancer. In contrast, laparoscopic total mesorectal excision (TME) for the treatment of rectal cancer has been welcomed with significantly less enthusiasm. While it is likely that patients with rectal cancer will experience the same benefits of early recovery and decreased postoperative pain from the laparoscopic approach, whether the same oncologic clearance, specifically an adequate TME can be obtained is of concern. The aim of the current study is to review the current level of evidence in the literature on laparoscopic rectal cancer surgery with regard to short-term and long-term oncologic outcomes. The data from 8 RCTs, 3 meta-analyses, and 2 Cochrane Database of Systematic Reviews was reviewed. Current data suggests that laparoscopic rectal cancer resection may benefit patients with reduced blood loss, earlier return of bowel function, and shorter hospital length of stay. Concerns that laparoscopic rectal cancer surgery compromises short-term oncologic outcomes including number of lymph nodes retrieved and circumferential resection margin and jeopardizes long-term oncologic outcomes has not conclusively been refuted by the available literature. Laparoscopic rectal cancer resection is feasible but whether or not it compromises short-term or long-term results still needs to be further studied.

Key Words: Rectal cancer, Laparoscopy, Total mesorectal excision, Anterior resection, Abdominoperineal resection



INTRODUCTION

Laparoscopic colon resection was introduced in 1991[1,2]. Concern for port site metastasis and inadequate oncologic clearance initially hampered its adoption in the treatment of colon and rectal malignancy[3-6]. However, recently large comparative studies and multiple prospective randomized control trials (RCTs) have reported equivalence in resection margin, lymph node collection, tumor recurrence, postoperative complications, and long-term outcomes between open and laparoscopic resection for colon cancer[7-12]. In addition, these studies demonstrated earlier recovery of bowel function, less postoperative pain, and decreased hospital stay with the laparoscopic approach which has heralded widespread acceptance for laparoscopic resection of colon cancer[8,9,13-16]. In contrast, laparoscopic total mesorectal excision (TME) for the treatment of rectal cancer has been welcomed with significantly less enthusiasm.

While it is likely that patients with rectal cancer will experience the same benefits of early recovery and decreased postoperative pain from the laparoscopic approach, whether the same oncologic clearance, specifically an adequate TME can be obtained is of concern[17-23]. Involvement of the circumferential resection margin (CRM) after TME is a prognostic factor for local recurrence[24-28]. Marijnen et al[29] found that in the Dutch Rectal Cancer Trial, 13.1% of patients with a positive CRM developed a local recurrence within 2 years of follow-up, whereas patients with a margin > 2 mm had a local recurrence rate of 3.3% at 2 years (P < 0.0001). Post-operative radiation did not lead to a reduction in the local recurrence rate (17.3% vs 15.7% local recurrence in patients with CRM < 1 mm with and without adjuvant radiotherapy respectively, P = 0.98)[29]. In addition, pre-operative radiotherapy had no significant effect on the prevention of local recurrence in patients with positive CRM (9.3% in the irradiated group vs 16.4% in the surgery alone group, P = 0.08) highlighting the importance of adequate surgery. In conventional open resection of rectal cancer, considerable variation between surgeons in oncologic outcomes has been demonstrated[30]. Differences in local recurrence and disease-free survival may be amplified by the technical challenges of laparoscopic proctectomy. While, the laparoscopic approach provides a magnified view compared to open surgery, TME and autonomic nerve preservation which are prerequisites for satisfactory oncologic and functional results require significant laparoscopic expertise[31]. A number of studies have reported on the safety and feasibility of laparoscopic low anterior resection (LAR) and abdominoperineal resection (APR) with TME but there is no level one evidence supporting laparoscopic TME in terms of oncologic outcomes[19,20,32-36]. The aim of this study is to provide a systematic review of the short-term and long-term oncologic outcomes of laparoscopic rectal cancer resection.

DATA SOURCE

Peer-reviewed papers published on laparoscopic rectal cancer resection were found by searching the following terms in the Ovid Medline, PubMed, and Cochrane Database of Systematic Reviews from 1993 to 2010: “laparoscopy”, “laparoscopic surgery”, and “rectal cancer”. Review articles found using the search terms “colon cancer” or “rectal cancer” and “laparoscopy” were also reviewed to find pertinent articles. All relevant articles were assessed and inclusion and exclusion criteria applied.

Study designs included prospective RCTs, meta-analyses, and Cochrane Database of Systematic Reviews. Studies were included if short-term outcomes, morbidity and mortality, or oncologic data specifically, recurrence rates, number of lymph nodes retrieved, margin status, and overall survival for patients undergoing curative laparoscopic rectal cancer resection were reported. When more than one trial containing overlapping patient inclusion periods and data was reported from the same institution, the most recent publication was included. Studies were excluded if they (1) reported both colonic and rectal outcomes, but did not analyze rectal cancer outcomes individually; (2) were non-randomized comparative trials, descriptive trials, or case reports; (3) were not published in the English language; and (4) reported on patients undergoing palliative treatment (non-curative surgical intent).

The majority of data on laparoscopic resection for rectal cancer come from non-randomized comparative and descriptive studies. The literature review yielded a total of 79 studies published in the English language from 1993 to 2010. Sixty-five studies were excluded because they were non-randomized comparative trials or descriptive trials. One meta-analysis was excluded because individual studies were not analyzed according to the site of disease or the type of resection. The remaining 2 Cochrane reviews, 3 meta-analyses, and 8 RCTs comparing laparoscopic vs open TME for rectal cancer form the basis of this review. When assessing the data on laparoscopic resection of rectal cancer it is important to remember that results may vary greatly based on level of the tumor, APR vs LAR, use of neoadjuvant chemoradiation, and completeness of TME.

OUTCOMES OF INTEREST

Intraoperative outcomes include: duration of operation, blood loss, length of incision, and conversion rate. Short-terms parameters of interest include: early post-operative complications (hemorrhage, anastomotic leak, wound complications, chest infection, prolonged ileus, incidence of pulmonary embolism or deep vein thrombosis, and urinary infection/retention), and mortality. Oncologic outcomes reviewed include: number of lymph nodes retrieved, margin status, completeness of TME, local recurrence, and overall survival.

Intraoperative results

The proven benefits of laparoscopy noted in colon cancer surgery including decreased intraoperative blood loss, smaller length of incision, less postoperative pain, faster recovery of intestinal function, and shorter length of hospital stay likely also apply to rectal cancer surgery[37]. In RCTs (Table 1) the mean operative time for open surgical resection of rectal cancer ranged from 106 to 284 min compared to 120 to 245 min for laparoscopic resection (Table 2). As expected, duration of operation was significantly longer in the laparoscopic group compared to the open group in 6 of the 8 RCTs[7,22,31,38-40]. Similar results were reported in RCTs of open vs laparoscopic resection for colon cancer. Zhou et al[35] reported both shorter open and laparoscopic operative times compared to other trials with no significant difference between the two operative approaches (120 min vs 106 min for laparoscopic vs open resection respectively, P = 0.051). However, no details were provided on tumor stage, conversion rate, or whether the analysis was performed on an intent-to-treat basis. Araujo et al[34] was the only RCT to demonstrate significantly shorter operative times with laparoscopic compared to open resection (228 min vs 284 min respectively, P = 0.04). However, they attributed these results to fact that the surgical team performing laparoscopic APR was the same whereas open APR was often performed by different surgical teams. In addition, extraction of the specimen from the perineum likely decreased operative time because there was not an abdominal incision to close.

Table 1 Patient characteristics from randomized control trials.
Ref.Patients
M/F
BMI
Age (yr)
% Pre-op ChemoRT
TotalOpenLapOpenLapOpenLapOpenLapOpenLap
Kang et al[40]340170170110/60110/6024.1 (3.2)24.1 (3.2)59.1 (9.9)57.8 (11.1)100100
Ng eet al[45]153  77  7648/2937/39NANA65.7 (12)66.5 (11.9)NANA
Lujan et al[31]20410310164/3962/39NANA66.0 (9.9)67.8 (12.9)74.872.3
Ng et al[39]  99  48  5130/1831/20NANA63.5 (12.6)63.7 (11.8)00
Guillou et al[7]/Jayne et al[12]343113230NANA26 (4)25 (4)69 (12)69 (11)NANA
Braga et al[38]168  85  8364/2155/28NANA65.3 (10.3)62.8 (12.6)14.116.9
Zhou et al[35]171  89  8243/4646/36NANA45 (30-81)44 (26-85)NANA
Araujo et al[34]  28  15  1310/59/425.6 (17.1-38.5)23.5 (21.7-24.6)56.4 (24-78)59.1 (31-75)15 (100%)13 (100%)
Table 2 Intraoperative characteristics of patients from randomized control trials.
Ref.Number of patients (%)
Conv %Op time (min)
Blood loss (mL)
Length of incision (cm)
TotalOpen
Lap
OpenLapOpenLapOpenLap
TotalLARAPRTotalLARAPR
Kang et al[40]340170146 (75.9)24 (14.1)170151 (88.8)19 (11.2)1.2197.0 (62.9)244.9 (75.4)a217.5 (150.0-400.0)200.0 (100.0-300.0)a20.0 (18.0-23.0)5.0 (4.5-6.0)
Ng et al[45]1537777 (100)0 (0)7676 (100)0 (0)30.3154.0 (70.3)213.1 (59.3)a337.3 (0-2542)280.0 (0-3000)NANS
Lujan et al[31]20410381 (78.6)22 (21.4)10177 (76.2)24 (23.8)7.9172.9 (59.4)193.7 (45.1)a234.2 (± 174.3)127.8 (± 113.3)aNANA
Ng et al[39]99480 (0)48 (100)510 (0)51 (100)9.8163.7 (43.4)213.5 (46.2)a555.6 (0-4720)321.7 (0-3000)
Guillou et al[7]/Jayne et al[12]34311379 (69.9)34 (30.1)230167 (72.6)63 (27.4)34180 135-220)135 (100-180)NANA22 (18-29)10 (6-17)
Braga et al[38]1688574 (87.1)11 (12.9)8376 (92)7 (84)7.2209 (72)262 (72)a396 (50-1600)213 (50-1600)a19.1 (± 3.1)5.8 ( 0.8)a
Zhou et al[35]1718989 (100)0 (0)8282 (100)0 (0)NA106 (80-230)120 (110-220)a92 (50-200)20 (5-120)aNANA
Araujo et al[34]28150 (0)15 (100)130 (0)13 (100)0284228aNANANANA

Two meta-analyses included operative time as an outcome of interest. Aziz et al[41] included 22 studies comparing laparoscopic vs open rectal cancer resection in 2071 patients and found that operative time was significantly increased with the laparoscopic group as compared to the open group with a weighted mean difference (WMD) of 40.18 (95% CI, 26.46-56.13). Gao et al[42] performed a meta-analysis of short-term outcomes after laparoscopic resection for rectal cancer based on 11 studies and included 643 patients which reported no difference in operating time between open and laparoscopic approaches with a WMD of 1.59 (1.2-1.98).

Intraoperative blood loss was significantly less for the laparoscopic group compared to the open group in 4 of 6 RCTs and ranged from 20 mL to 321.7 mL and from 92 mL to 555.6 mL in the laparoscopic and open groups respectively (Table 2)[31,35,38,40]. Araujo et al[34] did not specifically report on the amount of intraoperative blood loss but there was no statistically significant difference in the need for blood transfusions between the two groups which was attributed to the fact that in an APR the majority of blood loss occurs during the perineal portion of the case which is the same regardless of surgical access. A recent Cochrane review by Breukink et al[43] evaluating the safety and efficacy of elective laparoscopic TME for the resection of rectal cancer found that in the majority of studies blood loss was reduced with the laparoscopic approach although this did not translate to fewer blood transfusions. Length of incision was measured in 3 of 8 RCTs and ranged from an average of 5 cm to 10 cm with the laparoscopic approach compared to an average of 19.1 cm to 22 cm with the open approach (Table 2)[7,38,40].

Seven of the 8 trials reported a conversion rate which ranged from 0%-34% (Table 2)[7,12,22,31,34,38-40]. Conversion to the open approach was commonly defined as length of incision greater than the size needed for tumor extraction or premature abdominal incision to allow improved mobilization. In the majority of studies conversion to open surgery was required because of local tumor invasion or difficult dissection in a narrow pelvis although bulky tumor, dilated small bowel, dense adhesions, bleeding, rectal perforation, difficulty mobilizing the splenic flexure, failure to identify or injury to the ureter, ischemia of the descending colon, and anastomotic failure were also cited. Breukink et al[44] reported that 36 of 48 studies assessed conversion and showed a highly variable rate ranging from 0% to 33%. However, they report that the lack of consensus in the definition made results difficult to interpret. In addition, surgeon experience and patient selection criteria were often not mentioned.

Two trials reported particularly high rates of conversion. Ng et al[45] had a conversion rate of 30.3% but they did not routinely perform preoperative staging with computed tomography scans and therefore frequently converted after diagnostic laparoscopy. Twelve of the 23 patients randomized to laparoscopic surgery were converted to open due to local tumor invasion, bulky tumor, or dilated small bowel which may have been recognized by preoperative imaging. In the CLASICC trial the conversion rate for laparoscopic resection of rectal cancer was reported at 34% and attributed to excessive tumor fixation and uncertainty of tumor clearance[7]. Surgeon learning curve may account for this high rate of conversion as evidenced by the fact that the overall rate of conversion dropped by year of study from 38% in year one to 16% in year six. However, consistent with several non-randomized reports, in the CLASICC trial patients converted to open resection had a higher operative mortality compared to patients in the laparoscopic or open groups (9% vs 1% vs 5% respectively)[7]. Conversion was also associated with worse oncologic outcomes in nonrandomized comparative and descriptive studies[46].

Short-term oncologic outcomes

While the number of lymph nodes retrieved can vary based on age, gender, tumor site, use of pre-operative radiation, and tumor grade, the extent and quality of surgical resection can also have an impact on the number of nodes collected and is therefore often considered a surrogate marker of the oncologic completeness of the resection[47-53]. The American Joint Committee on Cancer recommends that at least 12 lymph nodes be examined in patients with rectal cancer to confirm the absence of nodal involvement by the tumor[54]. In addition, a number of studies have reported that the number of lymph nodes examined may be associated with patient outcome[55,56]. Six of the 8 RCTs reported the mean number of lymph nodes retrieved with a range of 5.5 to 17 nodes in the laparoscopic group compared to 11.6 to 18 nodes in the open group (Table 3)[22,31,34,38-40]. In 4 of the 6 trials the number of lymph nodes isolated was not significantly different based on surgical approach. Araujo et al[34] reported a significantly lower yield of lymph nodes with laparoscopic rectal resection compared to open resection (5.5 vs 11.9 respectively, P = 0.04). However, the number of lymph nodes obtained in the study by Lujan et al[31] was higher in the laparoscopic group (13.63 vs 11.57 in the laparoscopic vs open approach respectively, P = 0.026). They suggested that laparoscopy offered better dissection and accuracy due to better visualization and exposure of structures with less manipulation of the mesorectum especially in a narrow pelvis. Four of the 8 RCTs reported the use of pre-operative chemoradiation. In these trials, the mean number of lymph nodes retrieved ranged from 5.5 to 17 nodes in the laparoscopic group and from 11.6 to 18 nodes in the open group[31,34,38,40]. Anderson et al[57] found that in the 17 trials that reported the number of lymph nodes retrieved, the mean number of nodes was 10 for the laparoscopic group and 12 for the open group (P = 0.001) with the majority of trials reporting a median of 11 or fewer nodes obtained. In 9 of these 17 trials, both groups were treated with preoperative radiation therapy and reported a mean of 10 lymph nodes harvested in the laparoscopic group and 11 in the open group.

Table 3 Short-term oncologic outcomes of patients from randomized control trials.
Ref.LN
Positive margin (CRM/distal) (%)
OpenLapOpenLap
Kang et al[40]18 (13-24)17 (12-22)7 (4.1)/NA5 (2.9)/NA
Ng eet al[45]12 (7)11.5 (7.9)1 (1.3)/NA2 (2.6)/NA
Lujan et al[31]11.57 (5.10)13.63 (6.26)a3 (2.9)/04 (4.0)/0
Ng et al[39]13.0 (7)12.4 (6.7)2 (4.2)/NA3 (5.9)/NA
Guillou et al[7]/Jayne et al[12]NANA(14)/NA(16)/NA
Braga et al[38]13.6 (6.9)12.7 (7.3)2 (2.4)/01 (1.2)/0
Zhou et al[35]NANANANA
Araujo et al[34]11.95.5aNANA

One of the greatest concerns of laparoscopic TME is that obtaining a complete oncologic resection will be more difficult. Involvement of the circumferential or distal margin is one of the most important prognostic factors in rectal resection with TME and can lead to an increase in local recurrence and a reduction in survival. Radial margins of less than 2 mm are associated with a local recurrence rate of 16% compared to a significantly reduced local recurrence rate of 6% with margins greater than 2 mm[27]. Six of the 8 RCTs reported the involvement of the CRM and no difference was found by surgical approach (Table 3)[7,31,38-40,45]. In the majority of trials the rate of CRM involvement was less than 5%. Patients with positive radial margins often had tumor invading the pelvic side wall or adjacent structure and were frequently converted from a laparoscopic to an open procedure[39]. In the CLASICC study, the only multi-center trial, a positive CRM was identified in 14 of 97 (14%) patients with open surgery and in 30 of 193 (16%) patients with laparoscopic rectal resection (P = 0.8)[7]. Of patients undergoing anterior resection, the CRM was positive in 16 of 129 (12%) individuals in the laparoscopic group and in 4 of 64 (6%) individuals in the open group (P = 0.19). While there is a non-significant higher positivity of the CRM in the laparoscopic anterior resection group, this is once again likely due to the fact that the learning curve was not completed before the start of this study. Two RCTs reported on distal margin status and the incidence of distal margin positivity was not significantly different between the two surgical approaches and in fact was 0%[31,38]. All 3 meta-analyses and the Cochrane review by Breukink et al[44] found no difference in positive margins based on surgical access.

Postoperative course: Less postoperative pain, faster recovery of intestinal function, and shorter length of stay are important benefits of laparoscopic colorectal surgery. Only 3 of 8 RCTs compared the exact amount of post-operative pain medication and 2 of these studies reported a significant reduction in analgesic use in the laparoscopic group (Table 4)[39,40,45]. Zhou et al[35] did not quantify the exact usage of pain medication, but found no significant difference in the number of days parental analgesics were necessary (4.1 vs 3.9 in the open and laparoscopic groups respectively, P = 0.225).

Table 4 Short-term outcomes of patients in randomized control trial.
Ref.Length of stay (d)
Anastomotic leak (%)
Wound infection (%)
Ileus (%)
Pain/PCA use (mg) or (number of shots)
Mortality
OpenLapOpenLapOpenLapOpenLapOpenLapOpenLap
Kang et al[40]9 (8-12)8 (7-12)02 (1.2)11 (6.5)2 (1.2)a22 (12.9)17 (10)156.9 (117.0-185.2)107.2 (80.0-150.0)00
Ng eet al[45]10.0 (3-39)8.4 (2-32)a4 (5.2)1 (1.3)9 (11.7)5 (6.6)2 (2.6)1 (1.3)8.3 (0-49)4.9 (0-23)a3 (3.9)2 (2.6)
Lujan et al[31]9.9 (6.8)8.2 (7.3)10 (12)5 (6)2 (1.9)0 (0)8 (7.8)6 (5.9)NANA3 (2.9)2 (1.9)
Ng et al[39]11.5 (5-38)10.8 (5-27)NANA4 (8.3)0 (0)2 (4.2)1 (2.0)11.4 (0-49)6.0 (0-47)a1 (2.8)1 (2.5)
Guillou et al[7]/Jayne et al[12]13 (9-18)11 (9-15)9 (7) 26 (10)15 (12)33 (13)NANANANANANA
Braga et al[38]13.6 (6-80)10 (6-27)a9 (10.6)8 (9.6)13 (15.3)6 (7.2)2 (2.3)2 (2.4)NANA1 (1.2)1 (1.2)
Zhou et al[35]13.3 (3.4)8.1 (3.1)a3 (3.4)1 (1.2)NANANANANANA0 (0)0 (0)
Araujo et al[34]< 10.510.5NANANANANANANANA

Resumption of bowel function was usually reported on post-operative days 3 to 5 and ability to tolerate a solid food diet was reported on post-operative days 3 to 6[7,31,35,39,40,45]. In the majority of RCTs earlier bowel movements and diet advancement was reported with the laparoscopic approach. The return of bowel function and reduction in wound pain was thought to contribute to earlier discharge after laparoscopic surgery. While in a majority of trials, the length of stay was not significantly different between surgical approaches, there was a trend toward decreased length of stay with laparoscopic rectal surgery. Breukink et al[58] found that laparoscopic TME resulted in earlier return of normal diet, less pain, less narcotic use and a shorter hospital stay.

Complications: Rectal cancer surgery is associated with a high rate of morbidity and mortality. Post-operative mortality in RCTs ranged from 1%-4% and demonstrated no statistically significant difference based on surgical approach (Table 4). The rate of post-operative complications ranged from 6% to 69% and with the exception of Zhou et al[35] did not differ significantly between laparoscopic and open groups. Wound infection and urinary tract infection accounted for the majority of perioperative complications in both groups. There was a higher incidence of wound infection with the open approach however this did not reach statistical significance. Breukink et al[58] found no difference in morbidity between the laparoscopic and open groups although there was a trend toward lower morbidity with laparoscopic TME. Aziz et al[41] found no difference in perioperative morbidity between the 2 groups while Gao et al[42] found that the overall morbidity rate of the laparoscopic group was significantly lower than that of the open group.

Anastomotic leak is the most serious complication after sphincter sparing rectal cancer resection especially with neoadjuvant chemoradiation. In addition, development of an anastomotic leak is reported to be associated with decreased long-term survival and higher rates of local recurrence after curative resection for colorectal cancer[59-63]. Operative expertise and selective diversion in high risk patients has resulted in a anastomotic leak rate of 1%-17% in most published series studying laparoscopic resection for rectal cancer[46,64,65]. Consistent with reports from non-randomized comparative trials, RCTs demonstrated no significant difference in the incidence of anastomotic leak between the laparoscopic and open technique for the resection of rectal cancer (Table 4).

While the incidence of perioperative morbidity was not different based on surgical access, fewer patients had long-term complications with laparoscopic rectal cancer resection compared to the open approach. Adhesion related bowel obstruction was the most common long-term morbidity. With a median follow-up of greater than 9 years, Ng et al[45] found that adhesion-related obstruction requiring hospitalization (18.9% vs 2.7%) and re-operation (6.8% vs 0%) was higher in the open group. They report a cumulative probability of adhesion-related bowel obstruction at 10 years of 20.5% in the open group and 3.9% in the laparoscopic group (P = 0.001)[45]. Kuhry et al[66] performed a systematic review including 12 trials (3346 patients) to evaluate the long-term outcomes of laparoscopically assisted vs open surgery for resectable colorectal cancer. Data on long-term complications was not separated by site of disease but the overall occurrence of incisional hernia (7.9% vs 10.9%, P = 0.32) and reoperation for adhesions (1.1% vs 2.5%, P = 0.30) was not statistically difference between laparoscopic and open resection. Long-term studies need to be done to determine if laparoscopy decreases the incidence of intra-abdominal adhesion formation by reduced surgical trauma, less tissue handling, and smaller incisions.

Long-term oncologic outcomes

A number of the clinical trials were performed to determine the safety and feasibility of the laparoscopic approach for rectal adenocarcinoma and therefore the data we have for long-term outcomes is limited (Table 5). Braga et al[38] found no difference in local recurrence (4.0% in the laparoscopic group vs 5.2% in the open group, P = 0.97), overall five-year survival, or disease-free five-year survival based on surgical approach. With a median follow-up of 87.2 mo in the laparoscopic group and 90.1 mo in the open group, Ng et al[39] demonstrated that after curative resection, the probability of five-year survival was 75.2% vs 76.5% for laparoscopic vs open APR respectively (P = 0.20). In addition, stage-by-stage comparison for the two groups showed no statistical difference. There were no port site recurrences and overall recurrence rates were not significantly different between the two groups (laparoscopic 20% vs open 25%, P = 0.60). Despite the higher rate of circumferential margin positivity in patients undergoing laparoscopic anterior resection in the CLASICC trial, there was no difference in local recurrence, three- year overall or three-year disease free survival between the two approaches (open OS 66.7% and laparoscopic OS 74.6%, P = 0.17; open DFS 70.4% and laparoscopic DFS 70.9%, P = 0.72; open LR 7.0% and laparoscopic LR 7.98%, P = 0.70)[12]. In addition, there was no significant difference in the rates of local recurrence, three-year overall survival, or three-year disease-free survival in patients undergoing laparoscopic vs open APR[12]. However, the sample size is small and therefore larger studies are needed for conclusive results. Ng et al[45] published results of a randomized trial of laparoscopic vs open anterior resection for upper rectal cancer with a median follow-up of 9 years. No difference in local recurrence, overall survival, or disease-free survival was reported. Although these studies suggest comparative oncologic outcomes between laparoscopic and open rectal cancer resection, they include small sample sizes and are almost all are single institution studies, highlighting the need for large, multi-center RCTs to provide confirmatory data.

Table 5 Long-term oncologic outcomes of patients in randomized control trials.
Ref.Mean F/U (mo)
LR (%)
DFS (%)
OS (%)
OpenLapOpenLapOpenLapOpenLap
Kang et al[40]NANANANANANANANA
Ng eet al[45]108.8 (69.8-168.7)112.5 (71.1-168.3)7.14.980.4 (5.1)82.9 (4.9)55.1 (6.5)63.9 (6.6)
Lujan et al[31]34.1 (20)32.8 (18.9)5.34.88184.875.342.1
Ng et al[39]90.1 (27.0-145.5)87.2 (22.8-150.0)11.1573.6 (8.1)78.1 (6.9)76.5 (7.3)75.2 (7.2)
Guillou et al[7]/Jayne et al[12]36.8 (20.0-61.5)36.8 (20.0-61.5)10.19.770.4/46.970.9/49.866.7/57.774.6/65.2
Braga et al[38]53.653.65.24NANANANA
Zhou et al[35]1.0-16.01.0-16.0NANANANANANA
Araujo et al[34]47.247.213.30NANANANA

In a meta-analysis by Anderson et al[57] 18 of 24 studies reported recurrence rates. With a mean follow-up of 35 mo for both groups, overall local recurrence was not statistically different between the 2 groups (laparoscopic 7% vs open 8%, P = NS). Eleven studies provided sufficient data to compare overall survival. Overall survival was 72% for patients undergoing laparoscopic rectal cancer resection and 65% for open resection at an average of 4.4 years (P = 0.5). Subset analysis by Kuhry et al[66] demonstrated no significant difference between laparoscopic and open rectal cancer resection in terms of local recurrence (laparoscopic 7.2% vs open 7.8%, P = 0.46), development of distant metastases (laparoscopic 13.5% vs open 9.1%, P = 0.60), or cancer-related mortality (laparoscopic 9% vs open 10%, P = 0.16). While, this data is encouraging, it is no conclusive.

CONCLUSION

The primary goal of this study was to outline and review the short-term and long-term oncologic outcomes and complications of laparoscopic rectal cancer resection compared to the gold standard of conventional open resection currently available in the literature. Due to the heterogeneity in tumor stage, surgeon experience, and surgical technique, descriptive and non-randomized trials were not included in this review. However, because of the relatively few RCTs, information on the long-term outcomes is sparse and our conclusions are thus based on a small number of patients. A second limitation is that in a number of these trials data accrual started before the effectiveness of neoadjuvant therapy had been proven and thus the majority of patients did not receive pre-operative chemoradiation which is the current standard of care. Given these limitations, we found no difference in adequacy of oncologic resection, perioperative morbidity, recurrence rates, overall survival, or disease-free survival between open and laparoscopic rectal cancer resection.

In conclusion, RCTs have demonstrated that laparoscopy does not adversely affect cancer related survival in patients with adenocarcinoma of the colon. Concerns about the technical difficulty of TME may have contributed to the exclusion of rectal cancer patients from most of these large multicenter RCTs resulting in little data on oncologic outcomes with laparoscopic rectal cancer resection.

Laparoscopic rectal dissection is technically more demanding than open and constraints of a narrow pelvis may result in difficulty assessing and obtaining adequate surgical margins. However, there are several proposed benefits of laparoscopic rectal resection. A clear and magnified view of the pelvis provided by the improved optics of laparoscopy may aid sharp dissection for TME and assist in identification of vital pelvic structures including the ureters and autonomic nerves. In addition, pneumoperitoneum may separate the parietal and visceral fascia of the mesorectum facilitating dissection in this plane. Laparoscopic rectal cancer resection has a steep learning curve but increased experience with both open and laparoscopic TME will lead to shorter operating times and decreased morbidity[67].

Current data suggests that laparoscopic rectal cancer resection may benefit patients because of reduced blood loss, earlier return of bowel function, and shorter hospital length of stay[68,69]. Concerns that laparoscopic rectal cancer surgery may compromise short-term oncologic outcomes including number of lymph nodes harvested and CRM positivity do not appear to be supported by the available literature. However, there is a paucity of data concerning long-term oncologic outcomes and complications with laparoscopic rectal cancer surgery. There are two large, multicenter RCTs that are currently being conducted: the COLOR II trial in Europe and the ACOSOG-Z6051 trial in the United States[70]. Both of these studies are comparing the laparoscopic and open approach for treatment of resectable rectal cancer. Results from these trials will provide information on the long-term outcomes of laparoscopic rectal cancer resection and are eagerly awaited. In view of the lack of level one data on oncologic outcomes, laparoscopic TME for locally advanced, curable rectal cancer should only be performed within the confines of a RCT.

Footnotes

Peer reviewers: Dietmar Öfner, MD, MAS, MSc, Professor, Department of Surgery, Paracelsus Private Medical University Salzburg, Müllner Hauptstrasse 48, Salzburg 5020, Austria; Kjetil Soreide, MD, PhD, Associate Professor, Department of Surgery, Stavanger University Hospital, Armauer Hansensvei 20, POB 8100, N-4068 Stavanger, Norway, Philip H Gordon, Professor, Department of Surgery, McGill University, 3755 Cote Ste. Catherine Road, Suite G-314, Montreal, Quebec H3T 1E2, Canada; Vamsi R Velchuru, MRCS, FRCSEd, RCS (Gen Surg), James Paget University Hospital, Great Yarmouth, 6 Pickwick Drive, Off Market Lane, Blundeston NR32 5BX, United Kingdom

S- Editor Lv S L- Editor A E- Editor Xiong L

References
1.  Fowler DL, White SA. Laparoscopy-assisted sigmoid resection. Surg Laparosc Endosc. 1991;1:183-188.  [PubMed]  [DOI]
2.  Jacobs M, Verdeja JC, Goldstein HS. Minimally invasive colon resection (laparoscopic colectomy). Surg Laparosc Endosc. 1991;1:144-150.  [PubMed]  [DOI]
3.  Jacquet P, Averbach AM, Jacquet N. Abdominal wall metastasis and peritoneal carcinomatosis after laparoscopic-assisted colectomy for colon cancer. Eur J Surg Oncol. 1995;21:568-570.  [PubMed]  [DOI]
4.  Akle CA. Early parietal recurrence of adenocarcinoma of the colon after laparoscopic colectomy. Port site metastasis after laparascopic colorectal surgery for cure of malignancy. Br J Surg. 1996;83:427.  [PubMed]  [DOI]
5.  Wexner SD, Cohen SM. Port site metastases after laparoscopic colorectal surgery for cure of malignancy. Br J Surg. 1995;82:295-298.  [PubMed]  [DOI]
6.  Ramos JM, Gupta S, Anthone GJ, Ortega AE, Simons AJ, Beart RW. Laparoscopy and colon cancer. Is the port site at risk? A preliminary report. Arch Surg. 1994;129:897-899; discussion 900.  [PubMed]  [DOI]
7.  Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, Heath RM, Brown JM. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365:1718-1726.  [PubMed]  [DOI]
8.  Lacy AM, García-Valdecasas JC, Delgado S, Castells A, Taurá P, Piqué JM, Visa J. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet. 2002;359:2224-2229.  [PubMed]  [DOI]
9.  Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ, Haglind E, Påhlman L, Cuesta MA, Msika S. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol. 2005;6:477-484.  [PubMed]  [DOI]
10.  Law WL, Lee YM, Choi HK, Seto CL, Ho JW. Impact of laparoscopic resection for colorectal cancer on operative outcomes and survival. Ann Surg. 2007;245:1-7.  [PubMed]  [DOI]
11.  Milsom JW, Böhm B, Hammerhofer KA, Fazio V, Steiger E, Elson P. A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report. J Am Coll Surg. 1998;187:46-54; discussion 54-5.  [PubMed]  [DOI]
12.  Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, Smith AM, Heath RM, Brown JM. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol. 2007;25:3061-3068.  [PubMed]  [DOI]
13.  Kemp JA, Finlayson SR. Outcomes of laparoscopic and open colectomy: a national population-based comparison. Surg Innov. 2008;15:277-283.  [PubMed]  [DOI]
14.  Guller U, Jain N, Hervey S, Purves H, Pietrobon R. Laparoscopic vs open colectomy: outcomes comparison based on large nationwide databases. Arch Surg. 2003;138:1179-1186.  [PubMed]  [DOI]
15.  Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med. 2004;350:2050-2059.  [PubMed]  [DOI]
16.  Delaney CP, Chang E, Senagore AJ, Broder M. Clinical outcomes and resource utilization associated with laparoscopic and open colectomy using a large national database. Ann Surg. 2008;247:819-824.  [PubMed]  [DOI]
17.  Ströhlein MA, Grützner KU, Jauch KW, Heiss MM. Comparison of laparoscopic vs. open access surgery in patients with rectal cancer: a prospective analysis. Dis Colon Rectum. 2008;51:385-391.  [PubMed]  [DOI]
18.  Morino M, Allaix ME, Giraudo G, Corno F, Garrone C. Laparoscopic versus open surgery for extraperitoneal rectal cancer: a prospective comparative study. Surg Endosc. 2005;19:1460-1467.  [PubMed]  [DOI]
19.  Law WL, Lee YM, Choi HK, Seto CL, Ho JW. Laparoscopic and open anterior resection for upper and mid rectal cancer: an evaluation of outcomes. Dis Colon Rectum. 2006;49:1108-1115.  [PubMed]  [DOI]
20.  Kim SH, Park IJ, Joh YG, Hahn KY. Laparoscopic resection for rectal cancer: a prospective analysis of thirty-month follow-up outcomes in 312 patients. Surg Endosc. 2006;20:1197-1202.  [PubMed]  [DOI]
21.  Laurent C, Leblanc F, Gineste C, Saric J, Rullier E. Laparoscopic approach in surgical treatment of rectal cancer. Br J Surg. 2007;94:1555-1561.  [PubMed]  [DOI]
22.  Ng KH, Ng DC, Cheung HY, Wong JC, Yau KK, Chung CC, Li MK. Laparoscopic resection for rectal cancers: lessons learned from 579 cases. Ann Surg. 2009;249:82-86.  [PubMed]  [DOI]
23.  Leroy J, Jamali F, Forbes L, Smith M, Rubino F, Mutter D, Marescaux J. Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes. Surg Endosc. 2004;18:281-289.  [PubMed]  [DOI]
24.  Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, O'Callaghan C, Myint AS, Bessell E, Thompson LC. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821-828.  [PubMed]  [DOI]
25.  Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303-312.  [PubMed]  [DOI]
26.  Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996-999.  [PubMed]  [DOI]
27.  Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol. 2002;26:350-357.  [PubMed]  [DOI]
28.  Rullier A, Gourgou-Bourgade S, Jarlier M, Bibeau F, Chassagne-Clément C, Hennequin C, Tisseau L, Leroux A, Ettore F, Peoc'h M. Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: The French randomised trial ACCORD12/0405 PRODIGE 2. Eur J Cancer. 2012;Aug 18 [Epub ahead of print].  [PubMed]  [DOI]
29.  Marijnen CA, Nagtegaal ID, Kapiteijn E, Kranenbarg EK, Noordijk EM, van Krieken JH, van de Velde CJ, Leer JW. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys. 2003;55:1311-1320.  [PubMed]  [DOI]
30.  Akbari RP, Read TE. Laparoscopic rectal surgery: rectal cancer, pelvic pouch surgery, and rectal prolapse. Surg Clin North Am. 2006;86:899-914.  [PubMed]  [DOI]
31.  Lujan J, Valero G, Hernandez Q, Sanchez A, Frutos MD, Parrilla P. Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer. Br J Surg. 2009;96:982-989.  [PubMed]  [DOI]
32.  Staudacher C, Vignali A, Saverio DP, Elena O, Andrea T. Laparoscopic vs. open total mesorectal excision in unselected patients with rectal cancer: impact on early outcome. Dis Colon Rectum. 2007;50:1324-1331.  [PubMed]  [DOI]
33.  Law WL, Chu KW, Tung HM. Early outcomes of 100 patients with laparoscopic resection for rectal neoplasm. Surg Endosc. 2004;18:1592-1596.  [PubMed]  [DOI]
34.  Araujo SE, da Silva eSousa AH, de Campos FG, Habr-Gama A, Dumarco RB, Caravatto PP, Nahas SC, da Silva J, Kiss DR, Gama-Rodrigues JJ. Conventional approach x laparoscopic abdominoperineal resection for rectal cancer treatment after neoadjuvant chemoradiation: results of a prospective randomized trial. Rev Hosp Clin Fac Med Sao Paulo. 2003;58:133-140.  [PubMed]  [DOI]
35.  Zhou ZG, Hu M, Li Y, Lei WZ, Yu YY, Cheng Z, Li L, Shu Y, Wang TC. Laparoscopic versus open total mesorectal excision with anal sphincter preservation for low rectal cancer. Surg Endosc. 2004;18:1211-1215.  [PubMed]  [DOI]
36.  Baik SH, Gincherman M, Mutch MG, Birnbaum EH, Fleshman JW. Laparoscopic vs open resection for patients with rectal cancer: comparison of perioperative outcomes and long-term survival. Dis Colon Rectum. 2011;54:6-14.  [PubMed]  [DOI]
37.  McKay GD, Morgan MJ, Wong SK, Gatenby AH, Fulham SB, Ahmed KW, Toh JW, Hanna M, Hitos K. Improved short-term outcomes of laparoscopic versus open resection for colon and rectal cancer in an area health service: a multicenter study. Dis Colon Rectum. 2012;55:42-50.  [PubMed]  [DOI]
38.  Braga M, Frasson M, Vignali A, Zuliani W, Capretti G, Di Carlo V. Laparoscopic resection in rectal cancer patients: outcome and cost-benefit analysis. Dis Colon Rectum. 2007;50:464-471.  [PubMed]  [DOI]
39.  Ng SS, Leung KL, Lee JF, Yiu RY, Li JC, Teoh AY, Leung WW. Laparoscopic-assisted versus open abdominoperineal resection for low rectal cancer: a prospective randomized trial. Ann Surg Oncol. 2008;15:2418-2425.  [PubMed]  [DOI]
40.  Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW, Lim SB, Lee TG, Kim DY, Kim JS. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11:637-645.  [PubMed]  [DOI]
41.  Aziz O, Constantinides V, Tekkis PP, Athanasiou T, Purkayastha S, Paraskeva P, Darzi AW, Heriot AG. Laparoscopic versus open surgery for rectal cancer: a meta-analysis. Ann Surg Oncol. 2006;13:413-424.  [PubMed]  [DOI]
42.  Gao F, Cao YF, Chen LS. Meta-analysis of short-term outcomes after laparoscopic resection for rectal cancer. Int J Colorectal Dis. 2006;21:652-656.  [PubMed]  [DOI]
43.  Breukink SO, van der Zaag-Loonen HJ, Bouma EM, Pierie JP, Hoff C, Wiggers T, Meijerink WJ. Prospective evaluation of quality of life and sexual functioning after laparoscopic total mesorectal excision. Dis Colon Rectum. 2007;50:147-155.  [PubMed]  [DOI]
44.  Breukink S, Pierie J, Wiggers T. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev. 2006;CD005200.  [PubMed]  [DOI]
45.  Ng SS, Leung KL, Lee JF, Yiu RY, Li JC, Hon SS. Long-term morbidity and oncologic outcomes of laparoscopic-assisted anterior resection for upper rectal cancer: ten-year results of a prospective, randomized trial. Dis Colon Rectum. 2009;52:558-566.  [PubMed]  [DOI]
46.  Poon JT, Law WL. Laparoscopic resection for rectal cancer: a review. Ann Surg Oncol. 2009;16:3038-3047.  [PubMed]  [DOI]
47.  Vaccaro CA, Im V, Rossi GL, Quintana GO, Benati ML, Perez de Arenaza D, Bonadeo FA. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons. Dis Colon Rectum. 2009;52:1244-1250.  [PubMed]  [DOI]
48.  Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg. 2009;13:1337-1344.  [PubMed]  [DOI]
49.  Kim YW, Kim NK, Min BS, Lee KY, Sohn SK, Cho CH, Kim H, Keum KC, Ahn JB. The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer. J Surg Oncol. 2009;100:1-7.  [PubMed]  [DOI]
50.  Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer. 1994;73:2076-2082.  [PubMed]  [DOI]
51.  Sarli L, Bader G, Iusco D, Salvemini C, Mauro DD, Mazzeo A, Regina G, Roncoroni L. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer. 2005;41:272-279.  [PubMed]  [DOI]
52.  Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298:2149-2154.  [PubMed]  [DOI]
53.  Sjo OH, Merok MA, Svindland A, Nesbakken A. Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum. 2012;55:307-315.  [PubMed]  [DOI]
54.  Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin. 2004;54:295-308.  [PubMed]  [DOI]
55.  Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson AB, Cummings B, Gunderson L, Macdonald JS, Mayer RJ. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol. 2001;19:157-163.  [PubMed]  [DOI]
56.  Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912-2919.  [PubMed]  [DOI]
57.  Anderson C, Uman G, Pigazzi A. Oncologic outcomes of laparoscopic surgery for rectal cancer: a systematic review and meta-analysis of the literature. Eur J Surg Oncol. 2008;34:1135-1142.  [PubMed]  [DOI]
58.  Breukink SO, Pierie JP, Hoff C, Wiggers T, Meijerink WJ. Technique for laparoscopic autonomic nerve preserving total mesorectal excision. Int J Colorectal Dis. 2006;21:308-313.  [PubMed]  [DOI]
59.  Walker KG, Bell SW, Rickard MJ, Mehanna D, Dent OF, Chapuis PH, Bokey EL. Anastomotic leakage is predictive of diminished survival after potentially curative resection for colorectal cancer. Ann Surg. 2004;240:255-259.  [PubMed]  [DOI]
60.  McArdle CS, McMillan DC, Hole DJ. Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg. 2005;92:1150-1154.  [PubMed]  [DOI]
61.  Law WL, Choi HK, Lee YM, Ho JW, Seto CL. Anastomotic leakage is associated with poor long-term outcome in patients after curative colorectal resection for malignancy. J Gastrointest Surg. 2007;11:8-15.  [PubMed]  [DOI]
62.  Lin JK, Yueh TC, Chang SC, Lin CC, Lan YT, Wang HS, Yang SH, Jiang JK, Chen WS, Lin TC. The influence of fecal diversion and anastomotic leakage on survival after resection of rectal cancer. J Gastrointest Surg. 2011;15:2251-2261.  [PubMed]  [DOI]
63.  Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg. 2011;253:890-899.  [PubMed]  [DOI]
64.  Tan WS, Tang CL, Shi L, Eu KW. Meta-analysis of defunctioning stomas in low anterior resection for rectal cancer. Br J Surg. 2009;96:462-472.  [PubMed]  [DOI]
65.  Shiomi A, Ito M, Saito N, Ohue M, Hirai T, Kubo Y, Moriya Y. Diverting stoma in rectal cancer surgery. A retrospective study of 329 patients from Japanese cancer centers. Int J Colorectal Dis. 2011;26:79-87.  [PubMed]  [DOI]
66.  Kuhry E, Schwenk W, Gaupset R, Romild U, Bonjer J. Long-term outcome of laparoscopic surgery for colorectal cancer: a cochrane systematic review of randomised controlled trials. Cancer Treat Rev. 2008;34:498-504.  [PubMed]  [DOI]
67.  Kayano H, Okuda J, Tanaka K, Kondo K, Tanigawa N. Evaluation of the learning curve in laparoscopic low anterior resection for rectal cancer. Surg Endosc. 2011;25:2972-2979.  [PubMed]  [DOI]
68.  Staudacher C, Di Palo S, Tamburini A, Vignali A, Orsenigo E. Total mesorectal excision (TME) with laparoscopic approach: 226 consecutive cases. Surg Oncol. 2007;16 Suppl 1:S113-S116.  [PubMed]  [DOI]
69.  Pugliese R, Di Lernia S, Sansonna F, Maggioni D, Ferrari GC, Magistro C, Costanzi A, De Carli S, Artale S, Pugliese F. Laparoscopic resection for rectal adenocarcinoma. Eur J Surg Oncol. 2009;35:497-503.  [PubMed]  [DOI]
70.  Buunen M, Bonjer HJ, Hop WC, Haglind E, Kurlberg G, Rosenberg J, Lacy AM, Cuesta MA, D'Hoore A, Fürst A. COLOR II. A randomized clinical trial comparing laparoscopic and open surgery for rectal cancer. Dan Med Bull. 2009;56:89-91.  [PubMed]  [DOI]